Rhythm Pharmaceuticals
RYTM
RYTM
78 hedge funds and large institutions have $908M invested in Rhythm Pharmaceuticals in 2018 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 38 increasing their positions, 21 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
8% less funds holding
Funds holding: 85 → 78 (-7)
41% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 17
Holders
78
Holding in Top 10
6
Calls
–
Puts
–
Top Buyers
| 1 | +$22.1M | |
| 2 | +$15.8M | |
| 3 | +$14M | |
| 4 |
RCM
RA Capital Management
Boston,
Massachusetts
|
+$11.9M |
| 5 |
BlackRock
New York
|
+$11.5M |
Top Sellers
| 1 | -$29.9M | |
| 2 | -$29.2M | |
| 3 | -$9.86M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$5.86M |
| 5 |
MWNA
Marshall Wace North America
New York
|
-$4.31M |